Results 71 to 80 of about 4,117 (197)
Australasian Journal of Dermatology, Volume 67, Issue 5, Page 301-308, August 2026.ABSTRACT Background/Objectives Dupilumab is an anti‐interleukin (IL)‐4 receptor (IL‐4Rα) monoclonal antibody used to manage atopic dermatitis (AD). There is a paucity of real‐world Australian data for dupilumab in paediatric AD, especially regarding differences in clinical profiles between age groups.
Paul Sun Woo Kim +7 more
wiley +1 more source
Abrocitinib Monotherapy for Refractory Prurigo Nodularis: Report of Two Successful Cases [PDF]
Jingyao Liang,1,2,* Wei Li,1,2,* Wenyan Liu,1,2 Yihui Yu,1,2 Hui Ye,1,2 Xibao Zhang1,2 1Institute of Dermatology, Guangzhou Medical University, Guangzhou, Guangdong, 510095, People’s Republic of China; 2Department of Dermatology, Guangzhou ...
Li W +5 more
core
Evolving Evidence in the Neural Sensitization of Prurigo Nodularis
Prurigo nodularis is a chronic inflammatory skin disorder characterized by relentlessly pruritic, hyperkeratotic nodules. Recent studies have provided compelling evidence for the pivotal role of dysregulated interactions between the nervous and immune ...
Brooks, Sarah G, Yosipovitch, Gil
core +1 more source
Clinical Case ReportsPrurigo nodularis is a chronic pruritic condition that leads to a vicious itch‐scratch cycle, which can significantly impair quality of life. Low‐dose methotrexate is an effective option for patients with chronic nodular prurigo not responding to topical
Hamad El Hajj +4 more
doaj +1 more source
Treatment-resistant prurigo nodularis: challenges and solutions
, 2019 Eric H Kowalski,1 Diana Kneiber,1 Manuel Valdebran,2 Umangi Patel,1 Kyle T Amber1 1Department of Dermatology, University of Illinois at Chicago, Chicago, IL, USA; 2Department of Dermatology, University of California, Irvine, Irvine, CA, USA Abstract ...
Amber KT +4 more
core
Case report: Dupilumab-induced linear psoriasis: a rare presentation
Frontiers in MedicineA 42 year-old male with prurigo nodularis treated with dupilumab showed a case of linear psoriasis, highlighting the potential of dupilumab to induce immune shift and chimeric gene expression.
Wen Sun +6 more
doaj +1 more source
, 2019 Eric H Kowalski,1 Diana Kneiber,1 Manuel Valdebran,2 Umangi Patel,1 Kyle T Amber11Department of Dermatology, University of Illinois at Chicago, Chicago, IL, USA; 2Department of Dermatology, University of California-Irvine, Irvine, CA, USAKolli et al shed
Amber KT +4 more
core
Archivos argentinos de pediatria, 2009 Prurigos are a heterogeneous group of disorders of questionable or unknown etiology characterized by subjective symptoms such as accentuated itching and an eruption of chronic or recurrent papulonodules as an objective sign. They are divided into acute and chronic; acute forms being the most frequent in childhood.
Liz, Lezcano +4 more
openaire +1 more source
Chronic Prurigo of Nodular Type: A Review
Acta Dermato-Venereologica, 2017 Prurigo nodularis (PN) is a subtype of chronic prurigo presenting single to multiple symmetrically distributed, hyperkeratotic and intensively itching papules and nodules.
Claudia Zeidler +5 more
doaj +1 more source